Therapeutics is a biotechnology company developing therapies for spinal
cord injury, multiple sclerosis and related nervous system disorders.
Company's marketed products include Zanaflex Capsules(R) (tizanidine
a short-acting drug for the management of spasticity. Acorda's lead
product, Fampridine-SR, is in Phase3 clinical trials to evaluate its
and efficacy to improve walking ability in people with MS. The
pipeline includes a number of products in development for the
regeneration and repair of the spinal cord and brain.